These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 9309373

  • 41. [The serum bactericidal activity of domestic fleroxacin and lomefloxacin].
    Zhao M, Jiang S, Wang R.
    Zhonghua Nei Ke Za Zhi; 1999 Feb; 38(2):98-100. PubMed ID: 11798634
    [Abstract] [Full Text] [Related]

  • 42. [Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
    Trinchieri A, Marchetti F.
    Arch Ital Urol Androl; 2003 Mar; 75(1):49-52. PubMed ID: 12741347
    [Abstract] [Full Text] [Related]

  • 43. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH.
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [Abstract] [Full Text] [Related]

  • 44. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W.
    Chemotherapy; 1998 Sep; 44(2):77-84. PubMed ID: 9551236
    [Abstract] [Full Text] [Related]

  • 45. [Fleroxacin treatment for acute uncomplicated cystitis in women: comparison of 3-day and 7-day therapy].
    Ishihara S, Ban Y, Kawada Y, Ito S, Ito Y, Doi T, Nezasa S, Fujihiro S, Yamaha M, Ito F, Iwata H, Hasegawa Y, Ueno K, Shinoda I, Taniguchi M, Minoshima K, Takeuchi T, Sakai S, Uno H, Koide T.
    Hinyokika Kiyo; 1998 Jun; 44(6):431-6. PubMed ID: 9719946
    [Abstract] [Full Text] [Related]

  • 46. Randomized double-blind trial of high- and low-dose fleroxacin versus norfloxacin for complicated urinary tract infection.
    Pittman W, Moon JO, Hamrick LC, Cox CE, Clark J, Childs S, Pizzuti D, Fredericks J, St Clair P.
    Am J Med; 1993 Mar 22; 94(3A):101S-104S. PubMed ID: 8452163
    [Abstract] [Full Text] [Related]

  • 47. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA, Elston D, Akinlade BK, Weber K, Notario GF, Busman TA, Cifaldi M, Nilius AM.
    Curr Med Res Opin; 2006 Dec 22; 22(12):2419-28. PubMed ID: 17257456
    [Abstract] [Full Text] [Related]

  • 48. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group.
    Henry D, Ellison W, Sullivan J, Mansfield DL, Magner DJ, Dorr MB, Talbot GH.
    Antimicrob Agents Chemother; 1998 Sep 22; 42(9):2262-6. PubMed ID: 9736546
    [Abstract] [Full Text] [Related]

  • 49. Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections.
    Nichols RL, Smith JW, Gentry LO, Gezon J, Campbell T, Sokol P, Williams RR.
    South Med J; 1997 Dec 22; 90(12):1193-200. PubMed ID: 9404904
    [Abstract] [Full Text] [Related]

  • 50. Overview of cefdinir: pharmacokinetics, safety, and efficacy in the treatment of uncomplicated skin and skin structure infections.
    París MM, Devcich KJ.
    Cutis; 2004 May 22; 73(5 Suppl):14-8. PubMed ID: 15182160
    [Abstract] [Full Text] [Related]

  • 51. Acute, uncomplicated, lower urinary tract infections: the role of single-dose fleroxacin.
    Kosmidis J, Gargalianos P, Lelekis M, Adamis G, Petropoulou D, Makris D.
    J Chemother; 1989 Jul 22; 1(4 Suppl):864-5. PubMed ID: 16312675
    [No Abstract] [Full Text] [Related]

  • 52. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
    Schwab IR, Friedlaender M, McCulley J, Lichtenstein SJ, Moran CT, Levofloxacin Bacterial Conjunctivitis Active Control Study Group.
    Ophthalmology; 2003 Mar 22; 110(3):457-65. PubMed ID: 12623805
    [Abstract] [Full Text] [Related]

  • 53. Safety of fleroxacin in clinical trials.
    Geddes AM.
    Am J Med; 1993 Mar 22; 94(3A):201S-203S. PubMed ID: 8452181
    [Abstract] [Full Text] [Related]

  • 54. [Ten-year experience with the use of ofloxacin in the treatment of wound infection].
    Blatun LA, Iakovlev VP, Svetukhin AM, Puchkova LS, Izotova GN.
    Antibiot Khimioter; 1996 Mar 22; 41(9):73-6. PubMed ID: 9005792
    [Abstract] [Full Text] [Related]

  • 55. Ofloxacin once daily versus twice daily in community-acquired pneumonia and acute exacerbation of chronic bronchitis. A randomized multicenter study.
    Rayman J, Krchnavý M, Balciar P, Duchon J, Fortuník J, Faith L, Manduchova H, Drgona L, Koren P, Kraszko I, Krcméry V.
    Chemotherapy; 1996 Mar 22; 42(3):227-30. PubMed ID: 8983892
    [Abstract] [Full Text] [Related]

  • 56. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E, Esparza-Ahumada S, Morfin-Otero R.
    J Chemother; 1995 Jun 22; 7 Suppl 2():155-60. PubMed ID: 8622105
    [Abstract] [Full Text] [Related]

  • 57. Clinical studies of oral quinolone once daily in the treatment of lower respiratory tract infections.
    Yano T, Tanaka F, Ouchi K, Kawahara M, Fujino K, Shima R, Rikimaru T, Ichikawa Y, Oizumi K.
    Kurume Med J; 1993 Jun 22; 40(4):213-8. PubMed ID: 8007629
    [Abstract] [Full Text] [Related]

  • 58. Efficacy and tolerability of linezolid in treating severe skin and soft tissue infections caused by Gram-positive pathogens.
    Chen YS, Lee SC, Kim WJ.
    J Formos Med Assoc; 2004 May 22; 103(5):349-54. PubMed ID: 15216400
    [Abstract] [Full Text] [Related]

  • 59. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.
    Smith BL, Mogabgab WJ, Dalu ZA, Jones RB, Douglas JM, Handsfield HH, Hook EW, Viner BL, Shands JW, McCormack WM.
    Am J Med; 1993 Mar 22; 94(3A):81S-84S. PubMed ID: 8452187
    [Abstract] [Full Text] [Related]

  • 60. Efficacy and toxicity of fleroxacin in the treatment of travelers' diarrhea.
    Steffen R, Jori R, DuPont HL, Mathewson JJ, Stürchler D.
    Am J Med; 1993 Mar 22; 94(3A):182S-186S. PubMed ID: 8452178
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.